Weekly paclitaxel in women age 65 and above with metastatic breast cancer

Edith A. Perez, Charles L. Vogel, David H. Irwin, Jeffrey J. Kirshner, Ravi Patel

Research output: Contribution to journalArticle

36 Scopus citations


We evaluated therapy with weekly paclitaxel 80 mg/m2 in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with similar tolerability profiles in younger and older patients. Response rates and overall survival times were comparable in the two age groups (<65 and ≥65). Weekly paclitaxel therapy is a reasonable option for older patients with metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)85-88
Number of pages4
JournalBreast Cancer Research and Treatment
Issue number1
StatePublished - Jun 3 2002



  • Breast cancer
  • Elderly
  • Metastatic
  • Paclitaxel
  • Weekly

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this